Biogen looks to build $1.1bn manufacturing plant in Switzerland

By Zachary Brennan contact

- Last updated on GMT

Biogen looks to build $1.1bn manufacturing plant in Switzerland

Related tags: Switzerland

Biotech company Biogen plans to invest one billion Swiss francs ($1.1bn) in Solothurn, Switzerland to build a new production plant that will create about 400 new jobs beginning in 2019.

The announcement comes as Biogen believes rising demand for its current products, as well as potential demand from developing candidates, creates the need for additional manufacturing capacity.

Right now we have signed an ‘intent’ to build this facility, but it has not yet been approved by the community in Solothurn​,” Biogen spokeswoman Kate Niazi-Sai told us. “This announcement is part of our plan to bolster our current drug supply network to meet anticipated future demand for our products​.”

The planned facility would support the company’s other manufacturing site in Denmark, as well as its presence in Cambridge, Massachusetts and Research Triangle Park, NC.

Niazi-Sai added that the company has yet to reveal what products will be manufactured at the site or the types of equipment that will be deployed. The company, which has had a presence in Switzerland for a decade, currently employs 300 there.

Biogen’s current products help to treat multiple sclerosis and hemophilia, while its pipeline includes treatments for Alzheimer's and spinal muscular atrophy.

Related news

Related products

show more

Protect your bulk filtration and dispense step

Protect your bulk filtration and dispense step

Parker Bioscience Filtration | 20-Jan-2020 | Data Sheet

Does your process need greater protection when the value of your product is at its highest?

At the bulk filtration and container fill stage,...

Perfusion Using an ATF Cell Retention Device

Perfusion Using an ATF Cell Retention Device

Eppendorf for Bioprocess – Solutions that grow with you | 10-Dec-2019 | Application Note

Experimentation at small scale is crucial for the cost-efficient development of bioprocesses, which then can be transferred to larger volumes. We have...

Microaerobic Fermentation of Lactobacillus acidophilus

Microaerobic Fermentation of Lactobacillus acidophilus

Eppendorf for Bioprocess – Solutions that grow with you | 01-Oct-2019 | Application Note

We successfully performed microaerobic fermenta¬tion of a probiotic strain, Lactobacillus acidophilus, at a very low oxygen level, representing the natural...

rAAV Production in BioBLU® Single-Use Vessels

rAAV Production in BioBLU® Single-Use Vessels

Eppendorf for Bioprocess – Solutions that grow with you | 25-Jun-2019 | Application Note

Rising interest in gene therapy-based applications leads to increasing demands in scalable production systems for viral vectors. Find out how Cevec Pharmaceuticals...

Related suppliers

Follow us

Products

View more

Webinars